🔎 Trials Near Me

Почетна › Hronična limfocitna leukemija › Kalifornija › Los Angeles

Kliničke studije za Hronična limfocitna leukemija u gradu Los Angeles, CA

8 studija za Hronična limfocitna leukemija traži učesnike na lokacijama u gradu Los Angeles i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Тражи се учесникФаза 3
  • Kaiser Permanente Los Angeles Medical Center, Los Angeles
  • Kaiser Permanente West Los Angeles, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04269902

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Тражи се учесникФаза 3
  • UCLA Department of Medicine Hematologyoncology, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06846671

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Тражи се учесникФаза 3
  • Kaiser Permanente Los Angeles Medical Center, Los Angeles
  • Kaiser Permanente West Los Angeles, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Узраст 65 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07321652

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Тражи се учесникФаза 2
  • Cedars-Sinai Medical Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07221500

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Тражи се учесникФаза 1/2
  • Valkyrie Clinical Trials, Los Angeles
Узраст од 13 до 90 · Оба пола · Ажурирано 26. 10. 2026. · NCT06533579

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Тражи се учесникФаза 3
  • UCLA Department of Medicine Hematologyoncology, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06973187

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Тражи се учесникФаза 1/2
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
Узраст од 12 до 95 · Оба пола · Ажурирано 15. 4. 2026. · NCT04329728

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Тражи се учесникФаза 3
  • Valkyrie Clinical Trials /ID# 268151, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 9. 4. 2026. · NCT06428019

Studije za Hronična limfocitna leukemija u drugim gradovima

Ostale studije u gradu Los Angeles

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.